D. Symmons, Disease assessment indices: activity, damage and severity, Bailli??re's Clinical Rheumatology, vol.9, issue.2
DOI : 10.1016/S0950-3579(05)80190-6

H. Valleala, L. Laasonen, M. Koivula, J. Mandelin, C. Friman et al., Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebocontrolled clinical trial A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis, J Rheumatol Ann Intern Med J Rheumatol Ann Intern Med Ann Rheum Dis, vol.301242813664, issue.39, pp.468-73699, 1996.

K. Han, Prednisone treatment of elderly-onset rheumatoid arthritis. Disease activity and bone mass in comparison with chloroquine treatment, Arthritis Rheum, vol.38, pp.334-376, 1995.

S. Wassenberg, R. Rau, P. Steinfeld, and H. Zeidler, Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: A multicenter, double-blind, placebo-controlled trial, Arthritis & Rheumatism, vol.136, issue.11, pp.3371-80, 2005.
DOI : 10.1002/art.21421

R. Willkens, J. Sharp, D. Stablein, C. Marks, and R. Wortmann, Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis, Arthritis & Rheumatism, vol.36, issue.12, pp.1799-806, 1995.
DOI : 10.1002/art.1780381213